En Dirgaswara – In a significant move within the pharmaceutical industry, German biotechnology firm Evotec has announced a strategic partnership with Danish pharmaceutical giant Novo Nordisk aimed at advancing stem cell-based therapies. This collaboration focuses on addressing two of the most pressing health challenges of our time: diabetes and cardiovascular…